GPS Wealth Strategies Group’s TriSalus Life Sciences TLSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-233
Closed -$1.29K – 1439
2024
Q2
$1.29K Sell
233
-424
-65% -$3.6K ﹤0.01% 1243
2024
Q1
$6.41K Hold
657
– – ﹤0.01% 950
2023
Q4
$5.55K Hold
657
– – ﹤0.01% 963
2023
Q3
$3.36K Buy
+657
New +$5.38K ﹤0.01% 1045

Other funds holding TLSI

GPS Wealth Strategies Group's TLSI Position: Q3 2024 in Review

GPS Wealth Strategies Group sold out of TriSalus Life Sciences (TLSI) in Q3 2024, closing a stake of 233 shares — an estimated $1.29K sold.

GPS Wealth Strategies Group first reported a position in TLSI in Q3 2023 and held it in 4 quarters. The position peaked at $6.41K in Q1 2024. 32 funds tracked by Wall St. Rank hold TLSI as of Q3 2024.

  • GPS Wealth Strategies Group reported no remaining TriSalus Life Sciences position as of Q3 2024 after selling out during the quarter.
  • GPS Wealth Strategies Group sold 233 TriSalus Life Sciences shares in Q3 2024, an estimated $1.29K.
  • GPS Wealth Strategies Group first reported a position in TriSalus Life Sciences in Q3 2023 and held it in 4 quarters.
  • GPS Wealth Strategies Group's TriSalus Life Sciences position peaked at $6.41K in Q1 2024.
  • 32 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q3 2024.

Based on GPS Wealth Strategies Group's 13F filing for Q3 2024, filed 29 Oct 2024.